NCT05939401 A Study Regarding Tissue Response During and After Treatment for Anal Cancer
| NCT ID | NCT05939401 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sahlgrenska University Hospital |
| Condition | Anal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2023-12-01 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2023-12-01 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to improve the understanding for the tumour biology in relation to treatment response in patients with anal cancer by examining: * The tumour microenvironment * The localisation of and cellular interactions between the tumour and immune cells * The gene and protein expression by cells present in the tumour and surrounding tissue.
Eligibility Criteria
Inclusion Criteria: * Newly diagnosed or recurrent anal cancer Exclusion Criteria: * No diagnosis of anal cancer, contraindication to biopsies and blood samples
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05939401 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05939401 currently recruiting?
Yes, NCT05939401 is actively recruiting participants. Contact the research team at eva.angenete@gu.se for enrollment information.
Where is the NCT05939401 trial being conducted?
This trial is being conducted at Gothenburg, Sweden, Gothenburg, Sweden.
Who is sponsoring the NCT05939401 clinical trial?
NCT05939401 is sponsored by Sahlgrenska University Hospital. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.